What’s behind the cannabis stock market falls? by Steve Jones February 10, 2022April 29, 2024 Once among the hottest stocks in town, ASX-listed cannabis firms have fallen out of favour with […]
ACannabis is back, with an exclusive offer for Cannabiz members by cannabiz team February 8, 2022April 29, 2024
Medlab signs deal to promote Cann Group’s Satipharm product to doctors by Steve Jones February 1, 2022April 29, 2024
Company news: Cann Group; Releaf Group; Elixinol Wellness; Cronos Australia; Auscann; Zelira; Emyria; Incannex by cannabiz team October 21, 2021April 29, 2024
NZ industry calls for urgent review of Medicinal Cannabis Scheme as revenue slumps by Steve Jones October 7, 2021April 29, 2024
Company news: ECS Botanics; Cann Group; Medlab Clinical; Medibis by Martin Lane September 8, 2021April 26, 2024
Company news: Bod; Emyria; Cann Group; Health House; Releaf Clinics; Creso Pharma; Greenfern; Medlab by Martin Lane August 26, 2021April 26, 2024
Cann Group and Emyria go their separate ways on S3 registration by Martin Lane August 13, 2021April 26, 2024
A year of frustration but Cann Group vows to deliver for shareholders and consumers by Steve Jones August 12, 2021April 26, 2024